Looking for some bad pharma news? You've come to the right place. In this story, the Wall Street Journal reports on a gloomy forecast from Severin Schwan, CEO of Roche, who predicts that some drug makers will face bankruptcy or mergers due to a lack of "innovative medicines." He is quoted as saying, "Those who fail to bring sufficient innovation will be squeezed out of this market."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.